Share
Market Research Report

THERANOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Therapeutic AreaOncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Others) Cardiovascular Diseases · Neurological Disorders · Immunological Disorders · Others
  • By TechnologyPolymerase Chain Reaction (PCR) · Immunohistochemistry · In Situ Hybridization · Sequencing · Others
  • By End UserHospitals · Diagnostic Laboratories · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In06 Oct 2026
  • Report CodeCMI2043
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Theranostics Market Segmentation

  • By Therapeutic Area (Revenue, USD Bn, 2021-2033)

    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Others
    • Cardiovascular Diseases
    • Neurological Disorders
    • Immunological Disorders
    • Others
  • By Technology (Revenue, USD Bn, 2021-2033)

    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry
    • In Situ Hybridization
    • Sequencing
    • Others
  • By End User (Revenue, USD Bn, 2021-2033)

    • Hospitals
    • Diagnostic Laboratories
    • Others
  • By Region (Revenue, USD Bn, 2021-2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa